Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC2185
TNBC
Luminal
Sirolimus
MTOR
MTOR
7846.068
uM
0.00132
0.00221
-0.5384 -0.3084 0.9375 1.1035
0.9373
0.5039
HCC2185
TNBC
Luminal
Sirolimus
MTOR
MTOR
7464.069
uM
0.00147
0.00146
-0.1430 0.0071 2.1945 0.7708
0.9675
0.6495
HCC2185
TNBC
Luminal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7462.085
uM
7.59760
7.15830
-0.5274 0.0497 1.7575 0.3660
0.6025
0.3896
HCC2185
TNBC
Luminal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7463.084
uM
173.28310
360.46480
-0.7734 -1.0000 1.4999 0.3216
0.8080
0.7560
HCC2185
TNBC
Luminal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7464.084
uM
12.26940
52.37260
-0.9938 -1.0000 0.7570 0.5239
0.9749
0.8152
HCC2185
TNBC
Luminal
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7463.067
uM
11.36450
14.15710
-1.0000 -1.0000 5.0000 0.4092
0.9907
0.6688
HCC2185
TNBC
Luminal
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7464.067
uM
12.69390
15.8140
-0.9991 -0.9999 4.9987 0.3574
0.9942
0.7308
HCC2185
TNBC
Luminal
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7462.067
uM
12.63210
15.73730
-0.9999 -0.9999 4.9982 0.3425
0.9972
0.4873
HCC2185
TNBC
Luminal
TAPI-0
TACE/Collagenase
7462.096
uM
0.31064
0.30734
-0.0269 0.0260 5.0000 0.3485
0.9689
0.3514
HCC2185
TNBC
Luminal
Taxol
TUBB
TUBB
7848.002
uM
0.00463
0.00683
-0.3379 -0.3289 1.3012 0.8913
0.9640
0.5588
HCC2185
TNBC
Luminal
Taxol
TUBB
TUBB
9420.002
uM
0.00674
0.00772
-0.4979 -0.4884 5.0000 0.9765
0.9936
0.3242
HCC2185
TNBC
Luminal
Taxol
TUBB
TUBB
7849.002
uM
0.00876
0.00931
-0.1459 -0.1763 4.9996 0.7465
0.9941
0.5525
HCC2185
TNBC
Luminal
Taxol
TUBB
TUBB
9421.002
uM
0.00536
0.00657
-0.3820 -0.3593 2.6615 0.9054
0.9972
0.5336
HCC2185
TNBC
Luminal
TCS 2312
CHK1
CHK
12192.159
uM
1.54360
2.27160
-0.4495 -0.4850 1.7549 0.3806
0.9601
0.8215
HCC2185
TNBC
Luminal
TCS 2312
CHK1
CHK
10996.152
uM
1.22350
1.34990
-0.3239 -0.3172 5.0000 0.3252
0.9874
0.6343
HCC2185
TNBC
Luminal
TCS PIM-1 1
Pim kinase
PIM
12192.135
uM
inf
13.29170
0.6965 0.7063 4.8079 0.0782
0.6951
0.6212
HCC2185
TNBC
Luminal
Temsirolimus
MTOR
MTOR
12192.144
uM
0.00382
0.03008
-0.8304 -0.5780 0.3722 0.9625
0.8793
0.5798
HCC2185
TNBC
Luminal
Temsirolimus
MTOR
MTOR
10996.144
uM
0.00375
0.18883
-0.9997 -1.0000 0.2804 0.9938
0.8849
0.5116
HCC2185
TNBC
Luminal
Topotecan
TOP1
TOP
7849.043
uM
3.12740
4.96040
-0.3722 -0.3489 1.1476 0.3713
0.9195
0.3502
HCC2185
TNBC
Luminal
Topotecan
TOP1
TOP
7849.007
uM
0.03173
0.11605
-0.6989 -0.6087 0.6140 0.8354
0.9526
0.4353
HCC2185
TNBC
Luminal
Torkinib
15306.211
uM
0.00017
0.00130
-0.8220 -0.8191 0.4777 1.4061
0.9962
0.4935
HCC2185
TNBC
Luminal
Tozasertib
AURK/FLT3/ABL/JAK2
AURK
12192.16
uM
0.35927
0.12565
0.2935 0.3575 1.1951 0.2654
0.8281
0.7363
HCC2185
TNBC
Luminal
Tozasertib
AURK/FLT3/ABL/JAK2
AURK
10996.15
uM
0.22479
0.19030
0.0203 0.1302 1.8105 0.3260
0.9140
0.5092
HCC2185
TNBC
Luminal
TPCA-1
IKK
NFKB
7462.093
uM
5.50010
3.76590
0.3563 0.4248 5.0000 0.1224
0.9453
0.4426
HCC2185
TNBC
Luminal
Trametinib
MEK
MAPK
7846.05
uM
inf
inf
0.2930 0.2930 0.0000 0.3262
0.2659
0.3833